Pliant Therapeutics, Inc.PLRXNASDAQ

52-Week Range1-2

1.09Current 1.291.95

Want to monitor PLRX?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

pliant therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases.

Professional, Scientific, and Technical Services

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Bernard Coulie

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

SMX Redefines Trust, Provenance, and Transparency in the Global Luxury Market

Why Wall Street wasn't won over by Nvidia's big conference

OpenAI to expand ads on ChatGPT to all free and low-cost users, The Information reports

RR 13-DAY DEADLINE ALERT: Richtech Robotics (RR) Facing Securities Class Action Amid Questions About Possible Pump and Dump – Hagens Berman

BRBR 2-DAY DEADLINE ALERT: Hagens Berman Scrutinizing BellRing Brands (BRBR) Over Alleged Artificial Growth and $2.9 Billion Value Wipeout

Why This Vanguard ETF Is Hugely Popular -- Despite Underperforming the Market

2 AI Stocks That Didn't Get the Memo That the Bull Market Hit a Speed Bump

NuScale Power Corporation (SMR) Securities Fraud Class Action Lawsuit Filed; April 20, 2026, Lead Plaintiff Deadline

Even if You're Not Driving, You're Probably Using Oil

2 CEFs To Watch As A Rare Activist Battle Plays Out

Kyndryl Holdings, Inc. (KD) Class Action Lawsuit: Investors Face April 13, 2026, Deadline

Ocean Power Technologies: Record backlog drives revenue – ICYMI

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages GSI Technology Inc. Investors to Inquire About Securities Class Action Investigation - GSIT

3 Top EV Stocks With AI Upside to Buy Right Now

Sunstone Hotel: Locking In Attractive Yields With Its Preferred Stock

United Airlines slashes flights as Iran war sends fuel prices soaring

Sprout Social: Improving Fundamentals Pushing The Stock Into Deep Value Zone; Reiterating Buy

TRUBRIDGE ALERT: Bragar Eagel & Squire, P.C. is Investigating TruBridge, Inc. on Behalf of TruBridge Stockholders and Encourages Investors to Contact the Firm

Egypt says it will pay $1.3 billion in arrears to oil companies by June

1 Rule, 3 Stocks: Why One Legendary Investor Would Choose These Stocks Above Any Others Right Now

About